Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 212888

Expand all

CABENUVA KIT (CABOTEGRAVIR; RILPIVIRINE)
400MG/2ML (200MG/ML);600MG/2ML (300MG/ML)
Marketing Status: Prescription
Active Ingredient: CABOTEGRAVIR; RILPIVIRINE
Proprietary Name: CABENUVA KIT
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N212888
Product Number: 001
Approval Date: Jan 21, 2021
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information
CABENUVA KIT (CABOTEGRAVIR; RILPIVIRINE)
600MG/3ML (200MG/ML);900MG/3ML (300MG/ML)
Marketing Status: Prescription
Active Ingredient: CABOTEGRAVIR; RILPIVIRINE
Proprietary Name: CABENUVA KIT
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N212888
Product Number: 002
Approval Date: Jan 21, 2021
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English